Our Team
Our team is focused on rigorous science and efficient development to accelerate the delivery of first-ever treatment options. We collaborate closely with leading scientists and experts in disease biology, and our backgrounds include the deep technical, discovery, and entrepreneurial experience essential for pharmaceutical development.
Team
-

Katie Planey, PhD, MBA
Chief Executive Officer
-

Mark Forman, MD, PhD
Chief Development Officer &
Chief Medical Officer -

Lewis Whitehead, PhD
Senior Vice President of R&D, Computational Discovery
-

Vidhu Mathur, PhD
Vice President of R&D, Preclinical Biology
-

Valarie Truax, PhD, MBA
Vice President, Business Development and Corporate Strategy
-

Michael Robin
Vice President, Program Management & Operations
-

Marcie Glicksman, PhD
Acting Chief Scientific Officer
-

Shruti Arya, PhD
Senior Scientist I
-

Racquel Bruton, BA
Senior Director of Clinical Operations
-

Marcela Kokes, PhD
Associate Director of R&D, Preclinical Biology
-

Vanessa Seawright, MS
Research Associate II
-

Devi Supriya Korumilli, MS
Research Associate
-

Linda Szabo, PhD
Associate Director of Computational Biology
-

Andrew Carr, PhD
Senior Scientist
-

Cody Aldaz, PhD
Data Scientist II
-

Olivia Reidell, MS
Associate Program Manager
-

Vanessa Rivas
Chief of Staff
Advisors
-

Ambuj Singh, PhD
Founder & Board Member, Acelot; UCSB Professor, Department of Computer Science, Biomolecular Science and Engineering
-

David Bleakman, PhD
President, Drug Discovery Psychogenics; Former CSO, Eli Lilly Neuroscience; Former CSO, Redpin Therapeutics
-

Andrew Perlman, MD, PhD
Co-founder & Managing Director, X37; Former EVP, Tularik; Former CEO, Innate Immune; Former Director of Clinical Development, Genentech
-

Mike Kavanaugh, MD, PhD
CSO, Cytomx; Former CSO, Five Prime Therapeutics; Former VP, Novartis Vaccines & Diagnostics
-

Steve Doberstein, PhD
Former Chief Scientist, Nektar Therapeutics; Former Senior R&D, XOMA Royalty; Former Senior R&D, Five Prime Therapeutics; Former Senior R&D, Xencor; Former Senior R&D, Exelixis
Our Cultural Values